Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 382

1.

Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.

Van den Eynde E, Crespo M, Esteban JI, Jardi R, Ribera E, Carbonell J, Rodríguez-Frias F, Falco V, Curran A, Imaz A, Villar del Saz S, Ocaña I, Esteban R, Pahissa A.

Clin Infect Dis. 2009 Apr 15;48(8):1152-9. doi: 10.1086/597470. Erratum in: Clin Infect Dis. 2009 Aug 1;49(3):489.

2.

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients.

Dominguez S, Ghosn J, Valantin MA, Schruniger A, Simon A, Bonnard P, Caumes E, Pialoux G, Benhamou Y, Thibault V, Katlama C.

AIDS. 2006 May 12;20(8):1157-61. Review.

PMID:
16691067
3.

Optimizing outcomes in patients with hepatitis C virus genotype 1 or 4.

Lee SS, Ferenci P.

Antivir Ther. 2008;13 Suppl 1:9-16. Review.

PMID:
18432158
5.

Update on the treatment of chronic hepatitis C in HIV-infected patients.

Soriano V, Barreiro P, Martin-Carbonero L, Vispo E, Garcia-Samaniego J, Labarga P, Gonzalez-Lahoz J.

AIDS Rev. 2007 Apr-Jun;9(2):99-113. Review.

PMID:
17694677
6.

Rapid virologic response: a new milestone in the management of chronic hepatitis C.

Poordad F, Reddy KR, Martin P.

Clin Infect Dis. 2008 Jan 1;46(1):78-84. doi: 10.1086/523585. Review.

7.

Optimizing outcomes in patients with hepatitis C virus genotype 2 or 3.

Berg T, Carosi G.

Antivir Ther. 2008;13 Suppl 1:17-22. Review.

PMID:
18432159
8.

Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response.

Zeuzem S, Poordad F.

Curr Med Res Opin. 2010 Jul;26(7):1733-43. doi: 10.1185/03007995.2010.487038. Review.

PMID:
20482242
9.

Management of hepatitis C in HIV infected and other immunocompromised individuals.

Seth AK.

Trop Gastroenterol. 2006 Jul-Sep;27(3):111-7. Review.

PMID:
17310553
10.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
11.

[Chronic hepatitis C--patients "difficult to treat"].

Pawłowska M, Halota W.

Przegl Epidemiol. 2006;60(1):109-13. Review. Polish.

PMID:
16758748
12.

Reducing treatment duration in patients infected with hepatitis C genotype 1: any need for further studies?

Craxì A.

Antivir Ther. 2009;14(8):1045-9. doi: 10.3851/IMP1428. Review.

PMID:
20032534
13.

Viral factors affecting the outcome of therapy for chronic hepatitis C.

Fried MW.

Rev Gastroenterol Disord. 2004;4 Suppl 1:S8-S13. Review.

PMID:
15184819
14.

Into the light: strategies for battling hepatitis C.

Bacon BR, McHutchison JG.

Am J Manag Care. 2007 Dec;13 Suppl 12:S319-26. Review.

15.

Management of hepatitis C/HIV coinfection.

Rockstroh JK.

Curr Opin Infect Dis. 2006 Feb;19(1):8-13. Review.

PMID:
16374211
16.

Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis.

Andriulli A, Mangia A, Iacobellis A, Ippolito A, Leandro G, Zeuzem S.

Aliment Pharmacol Ther. 2008 Aug 15;28(4):397-404. doi: 10.1111/j.1365-2036.2008.03763.x. Epub 2008 Jun 11. Review.

17.

Management of chronic hepatitis C virus infection in HIV-infected patients.

Pol S, Soriano V.

Clin Infect Dis. 2008 Jul 1;47(1):94-101. doi: 10.1086/588669. Review.

18.

Hepatitis C treatment: shorter and better?

Araújo ES, Courtouké C, Barone AA.

Braz J Infect Dis. 2007 Feb;11(1):118-24. Review.

19.

Management of hepatitis C virus genotype 2 or 3 infection: treatment optimization on the basis of virological response.

Zeuzem S, Rizzetto M, Ferenci P, Shiffman ML.

Antivir Ther. 2009;14(2):143-54. Review.

PMID:
19430089
20.

Options for treatment of hepatitis C in HIV-infected persons.

Thomas DL.

J Hepatol. 2006;44(1 Suppl):S40-3. Epub 2005 Nov 28. Review.

PMID:
16356578
Items per page

Supplemental Content

Write to the Help Desk